BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harris M, Wang XG, Jiang Z, Goldberg GL, Casadevall A, Dadachova E. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line. Head Neck Oncol 2011;3:9. [PMID: 21314983 DOI: 10.1186/1758-3284-3-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Bryan RA, Jiang Z, Jandl T, Strauss J, Koba W, Onyedika C, Morgenstern A, Bruchertseifer F, Epstein AL, Dadachova E. Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA. Expert Rev Anticancer Ther 2014;14:1243-9. [PMID: 25156106 DOI: 10.1586/14737140.2014.952285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hu JM, Li L, Chen YZ, Pang LJ, Yang L, Liu CX, Zhao J, Chang B, Zou H, Qi Y, Liang WH, Li F. Human papillomavirus type 16 infection may be involved in esophageal squamous cell carcinoma carcinogenesis in Chinese Kazakh patients. Dis Esophagus 2013;26:703-7. [PMID: 23607265 DOI: 10.1111/dote.12009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Hillyar CR, Cornelissen B, Vallis KA. Uptake, internalization and nuclear translocation of radioimmunotherapeutic agents. Therapeutic Delivery 2014;5:319-35. [DOI: 10.4155/tde.14.6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Todorovic V, Prevc A, Zakelj MN, Savarin M, Brozic A, Groselj B, Strojan P, Cemazar M, Sersa G. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines. Radiat Oncol 2019;14:214. [PMID: 31775835 DOI: 10.1186/s13014-019-1418-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Lui VW, Grandis JR. Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer. Head Neck Pathol. 2012;6 Suppl 1:S91-S97. [PMID: 22782228 DOI: 10.1007/s12105-012-0364-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Dong Z, Hu R, Du Y, Tan L, Li L, Du J, Bai L, Ma Y, Cui H. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers. Front Immunol 2020;11:586796. [PMID: 33488587 DOI: 10.3389/fimmu.2020.586796] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pickhard A, Piontek G, Seidl C, Kopping S, Blechert B, Mißlbeck M, Brockhoff G, Bruchertseifer F, Morgenstern A, Essler M. ²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells. Nucl Med Biol 2014;41:68-76. [PMID: 24210808 DOI: 10.1016/j.nucmedbio.2013.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
8 Jiao R, Allen KJH, Malo ME, Helal M, Jiang Z, Smart K, Buhl SV, Rickles D, Bryan RA, Dadachova E. Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer. Cancer Med 2019;8:5289-300. [PMID: 31309741 DOI: 10.1002/cam4.2379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Nosanchuk JD, Dadachova E. Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens. Front Microbiol 2011;2:283. [PMID: 22275913 DOI: 10.3389/fmicb.2011.00283] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
10 Lau CY, Maldarelli F, Eckelman WC, Neumann RD. Rational development of radiopharmaceuticals for HIV-1. Nucl Med Biol 2014;41:299-308. [PMID: 24607432 DOI: 10.1016/j.nucmedbio.2014.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Bauman JE, Michel LS, Chung CH. New promising molecular targets in head and neck squamous cell carcinoma. Curr Opin Oncol 2012;24:235-42. [PMID: 22327839 DOI: 10.1097/CCO.0b013e3283517920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
12 Kranjc Brezar S, Prevc A, Niksic Zakelj M, Brozic A, Cemazar M, Strojan P, Sersa G. Synergistic effect of cisplatin chemotherapy combined with fractionated radiotherapy regimen in HPV-positive and HPV-negative experimental pharyngeal squamous cell carcinoma. Sci Rep 2020;10:1563. [PMID: 32005919 DOI: 10.1038/s41598-020-58502-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 V B, Femina T A, Iyengar D, K A, Ravi M. Approaches for Head and Neck Cancer Research - Current Status and the Way Forward. Cancer Invest 2021;:1-22. [PMID: 34806936 DOI: 10.1080/07357907.2021.2009850] [Reference Citation Analysis]
14 Todorovic V, Groselj B, Cemazar M, Prevc A, Zakelj MN, Strojan P, Sersa G. Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity. Radiol Oncol 2022. [PMID: 35390246 DOI: 10.2478/raon-2022-0014] [Reference Citation Analysis]
15 Zandberg DP, Bhargava R, Badin S, Cullen KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin. 2013;63:57-81. [PMID: 23258613 DOI: 10.3322/caac.21167] [Cited by in Crossref: 122] [Cited by in F6Publishing: 109] [Article Influence: 12.2] [Reference Citation Analysis]
16 Harris M, Wang XG, Jiang Z, Phaeton R, Koba W, Goldberg GL, Casadevall A, Dadachova E. Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein. Br J Cancer 2013;108:859-65. [PMID: 23385729 DOI: 10.1038/bjc.2013.43] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Bose P, Brockton NT, Dort JC. Head and neck cancer: from anatomy to biology. Int J Cancer 2013;133:2013-23. [PMID: 23417723 DOI: 10.1002/ijc.28112] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 10.3] [Reference Citation Analysis]
18 Phaeton R, Jiang Z, Revskaya E, Fisher DR, Goldberg GL, Dadachova E. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer. Cancer Med 2016;5:9-16. [PMID: 26625938 DOI: 10.1002/cam4.562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
19 Zeitlin R, Nguyen HP, Rafferty D, Tyring S. Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma. J Clin Med 2015;4:822-31. [PMID: 26239449 DOI: 10.3390/jcm4050822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]